The U.S. Centers for Disease Control and Prevention panel of vaccine experts will vote on shots for respiratory syncytial ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

De Amerikaanse Food and Drug Administration heeft maandag Merck's preventieve antilichaam goedgekeurd om zuigelingen tot één ...

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...

De Amerikaanse Food and Drug Administration (FDA) heeft maandag toestemming gegeven voor Merck’s preventieve antistofinjectie ...

Kennedy Jr. in the country's top health position, use of a long-approved vaccine against measles, mumps, rubella, and ...

The FDA approved mResvia for the prevention of RSV in people ages 18 to 59 years who are at increased risk for severe disease ...

"Let's chat RSV: the outpatient burden and novel preventive interventions" ...

Respiratory Syncytial Virus is a growing health concern for Indian infants. Efforts for maternal RSV vaccine faces challenges ...

A senior scientist at the U.S. Centers for Disease Control and Prevention (CDC) has resigned, warning that changes in ...